Aquestive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 7.78 M | $50.23 M | 19.15% | 7.03% |
| VANGUARD GROUP INC | 01/29/2026 | 5.89 M | $38.06 M | 4.07% | 5.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.37 M | $15.30 M | 13.42% | 2.14% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.03 M | $13.13 M | 159.36% | 1.84% |
| MORGAN STANLEY | 02/13/2026 | 1.76 M | $11.36 M | 24.72% | 1.59% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.19 M | $7.68 M | 804.61% | 1.07% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.17 M | $7.57 M | 6,233.38% | 1.06% |
| JANNEY MONTGOMERY SCOTT LLC | 02/11/2026 | 1.09 M | $7.06 M | -0.60% | 0.99% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 1.02 M | $6.59 M | -3.68% | 0.92% |
| HRT FINANCIAL LP | 02/12/2026 | 994.97 K | $6.43 M | 77.61% | 0.90% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 909.06 K | $5.87 M | 130.06% | 0.82% |
| ABRDN PLC | 01/16/2026 | 809.20 K | $5.23 M | 29.47% | 0.73% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/09/2026 | 525.00 K | $3.39 M | -58.00% | 0.47% |
| JANE STREET GROUP, LLC | 02/12/2026 | 512.22 K | $3.31 M | 592.63% | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 414.40 K | $2.68 M | 376.32% | 0.37% |
| JPMORGAN CHASE & CO | 02/11/2026 | 379.42 K | $2.45 M | -19.88% | 0.34% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 369.73 K | $2.39 M | 0.90% | 0.33% |
| NUVEEN, LLC | 02/12/2026 | 364.02 K | $2.35 M | -33.16% | 0.33% |
| EVERSTAR ASSET MANAGEMENT, LLC | 02/05/2026 | 344.80 K | $2.23 M | -6.38% | 0.31% |
| BARCLAYS PLC | 02/13/2026 | 340.81 K | $2.20 M | 158.66% | 0.31% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 301.52 K | $1.95 B | 18.63% | 0.27% |
| UBS GROUP AG | 01/29/2026 | 296.45 K | $1.92 M | -40.60% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 269.82 K | $1.74 M | 30.20% | 0.24% |
| SWISS NATIONAL BANK | 02/12/2026 | 202.70 K | $1.31 M | 100.00% | 0.18% |
| SEI INVESTMENTS CO | 02/13/2026 | 197.99 K | $1.28 M | 100.00% | 0.18% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 160.20 K | $1.03 M | 100.00% | 0.14% |
| EAM INVESTORS, LLC | 02/12/2026 | 155.05 K | $1.00 M | 1.79% | 0.14% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 120.25 K | $776.83 K | 100.00% | 0.11% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/09/2026 | 115.94 K | $748.95 K | 24.79% | 0.10% |
| LPL FINANCIAL LLC | 02/11/2026 | 102.39 K | $661.43 K | 13.91% | 0.09% |
| FINANCIAL ENGINES ADVISORS L.L.C. | 02/12/2026 | 97.48 K | $629.74 K | 1.81% | 0.09% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 91.54 K | $591.35 K | -9.40% | 0.08% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 83.43 K | $538.95 K | 11.53% | 0.08% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 81.90 K | $529.04 K | 885.38% | 0.07% |
| STRATOS WEALTH PARTNERS, LTD. | 01/20/2026 | 73.65 K | $475.79 K | 0.89% | 0.07% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 68.20 K | $454.21 K | 100.00% | 0.06% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 01/27/2026 | 65.01 K | $419.95 K | 100.00% | 0.06% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 64.70 K | $417.94 K | 239.58% | 0.06% |
| JANE STREET GROUP, LLC | 02/12/2026 | 61.80 K | $399.23 K | 166.38% | 0.06% |
| VERUS CAPITAL PARTNERS, LLC | 02/11/2026 | 60.80 K | $392.77 K | 80.95% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 58.16 K | $375.72 K | 19.55% | 0.05% |
| AXQ CAPITAL, LP | 02/10/2026 | 56.37 K | $364.13 K | -18.58% | 0.05% |
| SUGAR MAPLE ASSET MANAGEMENT, LLC | 01/20/2026 | 54.85 K | $354.33 K | 357.08% | 0.05% |
| CITIGROUP INC | 02/13/2026 | 51.53 K | $332.88 K | 1,030.54% | 0.05% |
| HBK SORCE ADVISORY LLC | 02/09/2026 | 42.55 K | $174.86 K | -0.23% | 0.04% |
| PENBROOK MANAGEMENT LLC | 01/06/2026 | 42.16 K | $272.35 K | -3.27% | 0.04% |
| MONECO ADVISORS, LLC | 02/04/2026 | 38.52 K | $248.81 K | 1.72% | 0.03% |
| ARCATAUR CAPITAL MANAGEMENT LLC | 01/27/2026 | 37.00 K | $239.02 K | 100.00% | 0.03% |
| LETKO, BROSSEAU & ASSOCIATES INC | 02/11/2026 | 35.33 K | $228.20 K | 100.00% | 0.03% |
| DAYMARK WEALTH PARTNERS, LLC | 01/12/2026 | 35.28 K | $227.90 K | 39.56% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aquestive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 179 institutional investors and hedge funds held shares of Aquestive Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD GROUP INC: 5.89 M
GEODE CAPITAL MANAGEMENT, LLC: 2.37 M
MORGAN STANLEY: 1.76 M
WELLS FARGO & COMPANY/MN: 1.19 M
BNP PARIBAS ARBITRAGE, SNC: 1.17 M
Janney Montgomery Scott LLC: 1.09 M
34.23% of Aquestive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 62.77 M shares in the last 24 months. This purchase volume represents approximately $229.11 M in transactions.